Vitreomacular traction after dexamethasone intravitreal implant (OZURDEX) injection: The effect of anomalous posterior vitreous detachment

7Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Purpose: To describe an unusual macular complication after dexamethasone intravitreal implant (Ozurdex) injection. Methods: Case history and macular optical coherence tomography findings are described. The report describes a patient with proliferative diabetic retinopathy and vitreoschisis who received Ozurdex treatment for diabetic macular edema. Results: After Ozurdex injection, visual acuity worsened because of newly formed vitreomacular traction that was demonstrated on optical coherence tomography imaging. A mechanism is proposed by which the medication might have contributed to this outcome. Conclusion: In this patient with vitreoschisis, a thickened posterior hyaloid membrane and traction developed after Ozurdex injection. The authors recommend careful evaluation of the macula before injection, particularly in diabetic patients with vitreoschisis.

Cite

CITATION STYLE

APA

Panjaphongse, R., & Stewart, J. M. (2016). Vitreomacular traction after dexamethasone intravitreal implant (OZURDEX) injection: The effect of anomalous posterior vitreous detachment. Retinal Cases and Brief Reports, 10(1), 55–57. https://doi.org/10.1097/ICB.0000000000000172

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free